Ratio Therapeutics
Boston, US
Biotech
Founders & leadership
JW
John W. HoppinExecutive Officer, Director
JB
John BabichDirector
MB
Marc BeckerExecutive Officer
SM
Scott MacDonaldExecutive Officer
WC
William CowanDirector
SW
Susan WhoriskeyDirector
AH
Albert HolmanDirector
AG
Allan GreenDirector
BI
Brandon IngersollDirector
Reported raises · per SEC filings
Form D private placements$70MraisedJul 2026 · 57 investors · Pharmaceuticals
finsmes.com ↗pharmaceutical-technology.com ↗Rule 506(b)$50.7MraisedDec 2023 · 46 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Ratio Therapeutics secures $70m in Series C funds for cancer radiotherapypharmaceutical-technology.com · 2026
- Ratio Therapeutics Raises $70M in Series C Fundingfinsmes.com · 2026
- Eli Lilly (LLY) Backs Ratio Therapeutics In $70 Million Cancer Funding Round - Simply Wall St Newssimplywall.st · 2026
- Ratio Therapeutics Closes $70 Million Series C Financing to Advance Clinical Development of Targeted Radiotherapeutics Pipeline and Expand Manufacturing Infrastructureprnewswire.com · 2026